AGP Picks
View all

Tech News St. Vincent & Grenadines
Provided by AGP

Tech News St. Vincent & Grenadines: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News St. Vincent & Grenadines.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on July 1, 2026

Amoéba has received marketing authorization in France for its biofungicide AXPERA
Jul. 1, 2026

Amoéba has received marketing authorization in France for its biofungicide AXPERA

Indeterminate GlobeNewswire
Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA
Jul. 1, 2026

Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA

Indeterminate GlobeNewswire
Amoéba obtém autorização de colocação no mercado em França para o seu biofungicida AXPERA
Jul. 1, 2026

Amoéba obtém autorização de colocação no mercado em França para o seu biofungicida AXPERA

Indeterminate GlobeNewswire
Amoéba ottiene l’autorizzazione all'immissione in commercio in Francia per il suo biofungicida AXPERA
Jul. 1, 2026

Amoéba ottiene l’autorizzazione all'immissione in commercio in Francia per il suo biofungicida AXPERA

Indeterminate GlobeNewswire
Abivax announces trading resumption of its ordinary shares on Euronext Paris
Jul. 1, 2026

Abivax announces trading resumption of its ordinary shares on Euronext Paris

Indeterminate GlobeNewswire
Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
Jul. 1, 2026

Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris

Indeterminate GlobeNewswire
SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma
Jul. 1, 2026

SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma

Indeterminate GlobeNewswire
Artelo Biosciences Announces New Data Supporting ART26.12 as a Potential First-in-Class Therapy for Chronic Pain associated with Spinal Cord Injury
Jul. 1, 2026

Artelo Biosciences Announces New Data Supporting ART26.12 as a Potential First-in-Class Therapy for Chronic Pain associated with Spinal Cord Injury

Indeterminate GlobeNewswire
Abivax annonce la fixation du prix de l’Offre au public largement sursouscrite de 800 M$ (702 M€) d’American Depositary Shares
Jul. 1, 2026

Abivax annonce la fixation du prix de l’Offre au public largement sursouscrite de 800 M$ (702 M€) d’American Depositary Shares

Indeterminate GlobeNewswire
Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
Jul. 1, 2026

Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

Indeterminate GlobeNewswire
BTCS Inc. Appoints Chris Janis to Its Board of Directors
Jul. 1, 2026

BTCS Inc. Appoints Chris Janis to Its Board of Directors

Indeterminate GlobeNewswire
Snail Announces Reverse Stock Split to Support Effort to Regain Compliance with Nasdaq’s Minimum Bid Price
Jul. 1, 2026

Snail Announces Reverse Stock Split to Support Effort to Regain Compliance with Nasdaq’s Minimum Bid Price

Indeterminate GlobeNewswire
Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop
Jul. 1, 2026

Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop

Indeterminate GlobeNewswire
Roper Technologies schedules second quarter 2026 financial results conference call
Jul. 1, 2026

Roper Technologies schedules second quarter 2026 financial results conference call

Indeterminate GlobeNewswire
NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026
Jul. 1, 2026

NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026

Indeterminate GlobeNewswire
Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer
Jul. 1, 2026

Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer

Indeterminate GlobeNewswire
Trust Stamp delivers a Custom-LLM model for an international telecommunications company and announces a shareholder call to unveil the Company’s strategic initiative to build and deliver Sovereign-AI implementations.
Jul. 1, 2026

Trust Stamp delivers a Custom-LLM model for an international telecommunications company and announces a shareholder call to unveil the Company’s strategic initiative to build and deliver Sovereign-AI implementations.

Indeterminate GlobeNewswire
Genius Group Reports Second Quarter 2026 Results: 112% Year-on-Year Revenue Growth, $4.3 million in Net Profit from operations.
Jul. 1, 2026

Genius Group Reports Second Quarter 2026 Results: 112% Year-on-Year Revenue Growth, $4.3 million in Net Profit from operations.

Indeterminate GlobeNewswire
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul. 1, 2026

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
BridgeBio Raises $1 Billion in Preferred Equity to Accelerate Present and Upcoming Launches
Jul. 1, 2026

BridgeBio Raises $1 Billion in Preferred Equity to Accelerate Present and Upcoming Launches

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech News St. Vincent & Grenadines

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.